Submitted by Anonymous (not verified) on 24 April 2026 - 13:52
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 10, Status: Authorised